Clinical Trial Update: CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery [Phase 1]

View source ↗

Summary

Pfizer-sponsored Phase 1 trial evaluating CP-751871 in women with early-stage breast cancer that can be removed by surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CP-751871

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Phase 1 | Status: WITHDRAWN